Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EJ9795 / 2||- / OT|
Administered by: Other Purchased by: ??
Symptoms: Cardio-respiratory arrest
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Medical History/Concurrent Conditions: Arrhythmia supraventricular; Cognitive disturbance; Hypertension arterial; Ischaemic heart disease
Diagnostic Lab Data:
CDC 'Split Type': FRPFIZER INC2021311540
Write-up: Cardio-respiratory arrest; This is a spontaneous report from a contactable physician downloaded from the regulatory authorian. This is a report received from the Regulatory Authority. An 87-year-old female patient received the second dose of BNT162B2 (COMIRNATY), intramuscular on 27Jan2021 (lot number: EJ9795) as single dose for COVID-19 vaccination. The patient''s medical history included ischaemic heart disease, arrhythmia supraventricular, cognitive disturbance, and hypertension arterial. The patient''s concomitant medications were not reported. The patient previously took the first dose of BNT162B2 (COMIRNATY) on 06Jan2021 for COVID-19 immunisation. The patient died due to cardio-respiratory arrest on 31Jan2021. It was not reported if an autopsy was performed.; Reported Cause(s) of Death: Cardio-respiratory arrest
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166